214 related articles for article (PubMed ID: 17697521)
1. No duplicate KRAS mutation is identified on the same allele in gastric or colorectal cancer cells with multiple KRAS mutations.
Kimura K; Nagasaka T; Hoshizima N; Sasamoto H; Notohara K; Takeda M; Kominami K; Iishii T; Tanaka N; Matsubara N
J Int Med Res; 2007; 35(4):450-7. PubMed ID: 17697521
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma.
Abubaker J; Bavi P; Al-Haqawi W; Sultana M; Al-Harbi S; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Uddin S; Al-Kuraya KS
J Pathol; 2009 Dec; 219(4):435-45. PubMed ID: 19824059
[TBL] [Abstract][Full Text] [Related]
3. [Detection of KRAS gene mutation and its clinical significance in colorectal adenocarcinoma].
Xu C; Liu YL; Huang J; He DM; Hou YY; Ji Y; Hou J; Lu SH; Xu JF; Hu Q; Shi Y; Zhao LJ; Tan YS
Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):667-70. PubMed ID: 23302307
[TBL] [Abstract][Full Text] [Related]
4. Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer.
Seth R; Crook S; Ibrahem S; Fadhil W; Jackson D; Ilyas M
Gut; 2009 Sep; 58(9):1234-41. PubMed ID: 19474002
[TBL] [Abstract][Full Text] [Related]
5. Detection of KRAS codon 12 and 13 mutations by mutant-enriched PCR assay.
Chang YS; Er TK; Lu HC; Yeh KT; Chang JG
Clin Chim Acta; 2014 Sep; 436():169-75. PubMed ID: 24863805
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of KRAS gene mutations in colorectal cancer--preliminary study.
Dinu D; Dobre M; Panaitescu E; Bîrlă R; Iosif C; Hoara P; Caragui A; Boeriu M; Constantinoiu S; Ardeleanu C
J Med Life; 2014; 7(4):581-7. PubMed ID: 25713627
[TBL] [Abstract][Full Text] [Related]
7. KRAS mutation profile in colorectal carcinoma and novel mutation--internal tandem duplication in KRAS.
Wójcik P; Kulig J; Okoń K; Zazula M; Moździoch I; Niepsuj A; Stachura J
Pol J Pathol; 2008; 59(2):93-6. PubMed ID: 18669174
[TBL] [Abstract][Full Text] [Related]
8. KRAS analysis in colorectal carcinoma: analytical aspects of Pyrosequencing and allele-specific PCR in clinical practice.
Sundström M; Edlund K; Lindell M; Glimelius B; Birgisson H; Micke P; Botling J
BMC Cancer; 2010 Dec; 10():660. PubMed ID: 21122130
[TBL] [Abstract][Full Text] [Related]
9. Companion-diagnostic testing limited to KRAS codons 12 and 13 misses 17% of potentially relevant RAS mutations in colorectal cancer.
Netzel BC; Grebe SK
Clin Chim Acta; 2013 Oct; 425():1-2. PubMed ID: 23832066
[TBL] [Abstract][Full Text] [Related]
10. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas].
Zhang X; Wang Y; Gao N; Wang J
Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):77-82. PubMed ID: 24742565
[TBL] [Abstract][Full Text] [Related]
11. KRAS mutation testing in colorectal cancer: comparison of the results obtained using 3 different methods for the analysis of codons G12 and G13.
Bihl MP; Hoeller S; Andreozzi MC; Foerster A; Rufle A; Tornillo L; Terracciano L
Diagn Mol Pathol; 2012 Mar; 21(1):14-23. PubMed ID: 22306671
[TBL] [Abstract][Full Text] [Related]
12. Sensitive multiplex detection of KRAS codons 12 and 13 mutations in paraffin-embedded tissue specimens.
Laosinchai-Wolf W; Ye F; Tran V; Yang Z; White R; Bloom K; Choppa P; Labourier E
J Clin Pathol; 2011 Jan; 64(1):30-6. PubMed ID: 21030527
[TBL] [Abstract][Full Text] [Related]
13. KRAS mutational status of endoscopic biopsies matches resection specimens.
Yang QH; Schmidt J; Soucy G; Odze R; Dejesa-Jamanila L; Arnold K; Kuslich C; Lash R
J Clin Pathol; 2012 Jul; 65(7):604-7. PubMed ID: 22461648
[TBL] [Abstract][Full Text] [Related]
14. [Correlation between KRAS mutations and clinicopathologic features in colorectal carcinomas].
Gao J; Zhang J; Lu T; Li XY; Jia N; Liang ZY
Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):595-8. PubMed ID: 23157826
[TBL] [Abstract][Full Text] [Related]
15. Optimization of routine KRAS mutation PCR-based testing procedure for rational individualized first-line-targeted therapy selection in metastatic colorectal cancer.
Chretien AS; Harlé A; Meyer-Lefebvre M; Rouyer M; Husson M; Ramacci C; Harter V; Genin P; Leroux A; Merlin JL
Cancer Med; 2013 Feb; 2(1):11-20. PubMed ID: 24133623
[TBL] [Abstract][Full Text] [Related]
16. The proto-oncogene KRAS and BRAF profiles and some clinical characteristics in colorectal cancer in the Turkish population.
Ozen F; Ozdemir S; Zemheri E; Hacimuto G; Silan F; Ozdemir O
Genet Test Mol Biomarkers; 2013 Feb; 17(2):135-9. PubMed ID: 23297805
[TBL] [Abstract][Full Text] [Related]
17. Comparison of two different screening methods for the KRAS mutation in colorectal cancer.
Er TK; Chang YS; Yeh KT; Chang TJ; Chang JG
Clin Lab; 2010; 56(5-6):175-86. PubMed ID: 20575464
[TBL] [Abstract][Full Text] [Related]
18. Frequency and type of KRAS mutations in routine diagnostic analysis of metastatic colorectal cancer.
Neumann J; Zeindl-Eberhart E; Kirchner T; Jung A
Pathol Res Pract; 2009; 205(12):858-62. PubMed ID: 19679400
[TBL] [Abstract][Full Text] [Related]
19. Detection of low-abundance KRAS mutations in colorectal cancer using microfluidic capillary electrophoresis-based restriction fragment length polymorphism method with optimized assay conditions.
Zhang H; Song J; Ren H; Xu Z; Wang X; Shan L; Fang J
PLoS One; 2013; 8(1):e54510. PubMed ID: 23355875
[TBL] [Abstract][Full Text] [Related]
20. Delineation of the infrequent mosaicism of KRAS mutational status in metastatic colorectal adenocarcinomas.
Bossard C; Küry S; Jamet P; Senellart H; Airaud F; Ramée JF; Bézieau S; Matysiak-Budnik T; Laboisse CL; Mosnier JF
J Clin Pathol; 2012 May; 65(5):466-9. PubMed ID: 22259183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]